Adherence in people living with HIV/AIDS, mental illness, and chemical dependency: A review of the literature

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 16, Issue SUPPL. 1, 2004, Pages

  Uldall, Karina K ^a,e   Palmer, N B ^b   Whetten, K ^c   Mellins, C ^d  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

^c DUKE UNIVERSITY   (United States)

^d NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALCOHOL ABUSE; COCAINE DEPENDENCE; DEMENTIA; DISEASE MARKER; DISEASE SEVERITY; DRUG EFFICACY; EPIDEMIOLOGICAL DATA; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MENTAL DISEASE; MOOD DISORDER; MORBIDITY; MORTALITY; OPIATE ADDICTION; PATIENT COMPLIANCE; PATIENT EDUCATION; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; SIDE EFFECT; SUBSTANCE ABUSE;

ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ATTITUDE TO HEALTH; FEMALE; HIV INFECTIONS; HUMANS; MALE; MENTAL DISORDERS; PATIENT COMPLIANCE; SUBSTANCE-RELATED DISORDERS;

EID: 10344250986     PISSN: 09540121     EISSN: None     Source Type: Journal    
DOI: 10.1080/09540120412331315277     Document Type: Review

References (191)

1. Aloisi, M. S., Arici, C., Balzano, R., Noto, P., Piscopo, R., Filice, G., Menichetti, F., Monforte, A. D., Ippolito, G., & Girardi, E. (2002). Behavioral correlates of adherence to antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes, 31, S145-S148.
2. Altice, F. L. (2004). Directly observed antiretroviral therapy among active drug users. Grant number 5RO1DAO13805, NIH CRISP.
3. Altice, F. L., Mostashari, F., & Friedland, G. H. (2001). Trust and acceptance of and adherence to antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes, 28, 47-58.
4. Amador, X. F., Strauss, D. H., & Yale, S. A. (1991). Awareness of illness in schizophrenia. Schizophrenia Bulletin, 17, 113-132.
5. American Academy of Neurology AIDS Task Force (1991). Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus type-1 infection. Neurology, 41, 778-785.
6. Ammassari, A., Trotta, M. P., Muirri, R., Castelli, F., Narciso, P., Noto, P., Vecchiet, J., Monforte, A. D., Wu, A. W., & Antinori, A. (2002). Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature. Journal of Acquired Immune Deficiency Syndromes, 31, S123-S127.
7. Andersen, R., Bozzette, S., Shapiro, M., St Clair, P., Morton, S., Crystal, S., Goldman, D., Wenger, N., Gifford, A., Leibowitz, A., Asch, S., Berry, S., Nakazono, T., Heslin, K., & Cunningham, W. (2000). Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the United States. Health Services Research, 35, 389-416.
8. Angelino, A. F., & Treisman, G. J. (2001). Management of psychiatric disorders in patients infected with human immunodeficiency virus. Clinical Infectious Diseases, 33(6), 847-856.
9. Arnsten, J. H. (2004). Efficacy and cost of HAART DOT in methadone clinics. Grant number 1RO1DAO15302, NIH CRISP.
10. Arnsten, J. H., Demas, P. A., Farzadegan, H., Grant, R. W., Gourevitch, M. N., & Chang, C. J. (2001). Antiretroviral therapy adherence and viral load suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clinical Infectious Disease, 33, 1417-1423.
11. Arnsten, J. H., Demas, P. A., Grant, R. W., Gourevitch, M. N., Farzadegan, H., Howard, A. A., & Schoenbaum, E. E. (2002). Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. Journal of General Internal Medicine, 17, 377-381.
12. Atkinson, J. H. (2004). Better antiretroviral adherence: HIV+ amphetamine users. Grant number 5RO1DA012800, NIH CRISP.
13. Avants, S. (2004). Interventions for HIV-positive drug abusers. Grant number 5K02DA015295, NIH CRISP.
14. Avants, S. K., Margolin, A., & Warburton, L. A. (2001). Predictors of non-adherence to HIV-related medication regimens during methadone stabilization. American Journal of Addictions, 10, 69-78.
15. Aversa, S. L., & Kimberlin, C. (1996). Psychosocial aspects of antiretroviral medication use among HIV patients. Patient Education and Counseling, 29, 207-219.
16. Bamberger, J. D., Unick, J., Klein, P., Fraser, M., Chesney, M., & Katz, M. H. (2000). Helping the urban poor stay with antiretroviral HIV drug therapy. American Journal of Public Health, 90, 699-701.
17. Bangsberg, D. R. (2004a). Depression treatment to improve ARV therapy adherence. Grant number 5RO1MH063011, NIH CRISP.
18. Bangsberg, D. R. (2004b). A RCT of HIV adherence case management and modified DOT. Grant number 1RO1MH064388, NIH CRISP.
19. Bangsberg, D. R., Hecht, F. M., & Charlebois, E. D. (2000). Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS, 14, 357-366.
20. Bangsberg, D. R., Hecht, F. M., Clague, H., Charlebois, E. D., Ciccarone, D., Chesney, M., & Moss, A. (2001). Provider assessment of adherence to HIV antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes, 26, 435-442.
21. Bangsberg, D. R., Bronstone, A., Chesney, M. A., & Hecht, F. M. (2002). Computer-assisted self-interviewing (CASI) to improve provider assessment of adherence in routine clinical practice. Journal of Acquired Immune Deficiency Syndromes, 31, S107-S111.
22. Bartko, G., Herczeg, I., & Zador, G. (1988). Clinical symptomatology and drug compliance in schizophrenic patients. Acta Psychiatrica Scandinavica, 77, 74-76.
23. Bartlett, J., Masi, R. de Quinn, J., Moxham, C., & Rousseau, F. (2000). Correlations between antiretroviral pill burden and durability of virologic response: a systematic overview. XIII International AIDS Conference (abstract ThPeB4998), Durban, South Africa.
24. Bassetti, S., Battegay, M., & Furrer, H. (1999). Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? Journal of Acquired Immune Deficiency Syndrome, 21, 114-119.
25. Battaglioli-Denero, A., Gallucci, A., Fish, D., Stellrecht, K., Piliero, P., & Clifford, G. (2002). Effect of an adherence program on HIV viral load in treatment experienced patients with a history of substance abuse and mental illness. XIV International AIDS Conference, abstract MoPeB3300, Barcelona, Spain.
26. Bing, E. G., Kilbourne, A. M., Brooks, R. A., Lazarus, E. F., & Senak, M. (1999). Protease inhibitor use among a community sample of people with HIV disease. Journal of Acquired Immune Deficiency Syndromes, 20, 474-480.
27. Bing, E. G., Burnam, M. A., Longshore, D., Fleishman, J. A., Sherbourne, C. D., London, A. S., Turner, B. J., Eggan, F., Beckman, R., Vitiello, B., Morton, S. C., Orlando, M., Bozzette, S. A., Ortiz-Barron, L., & Shapiro, M. (2001). Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Archives of General Psychiatry, 58, 721-728.
28. Blank, M. B. (2004). Nursing intervention for HIV regimen adherence among seriously mentally ill. Grant number 1RO1NR008851, NIH CRISP.
29. Bogart, L. M., Catz, S. L., Kelly, J. A., & Benotsch, E. G. (2000a). Factors influencing physicians' judgements of adherence and treatment decisions for patients with HIV disease. Medical Decision Making, 21, 28-36.
30. Bogart, L. M., Kelly, J. A., Catz, S. L., & Sosman, J. M. (2000b). Impact of medical and nonmedical factors on physician decision making for HIV/AIDS antiretroviral treatment. Journal of Acquired Immune Deficiency Syndromes, 23, 396-404.
31. Bouhnik, A. D., Chesney, M., Carrieri, P., Gallais, H., Moreau, J., Moatti, J. P., Obadia, Y., Spire, B., & MANIF 2000 Study Group (2002). Nonadherence among HIV-infected injecting drug users: the impact of social instability. Journal of Acquired Immune Deficiency Syndromes, 31, S149-S153.
32. Broadhead, R. S. (2004). Increasing drug users' adherence to HIV therapeutics. Grant number 5RO1DA012112, NIH CRISP.
33. Broadhead, R. S., Heckathorn, D. D., Altice, F. L., Hulst, Y., van Carbone, M., Friedland, G. H., O'Connor, P. G., & Selwyn, P. A. (2002). Increasing drug users' adherence to HIV treatment: results of a peer-driven intervention feasibility study. Social Science and Medicine, 55, 235-246.
34. Brooner, R. K., Greenfield, L., Schmidt, C. W., & Bigelow, G. E. (1993). Antisocial personality disorder and HIV infection among intravenous drug abusers. American Journal of Psychiatry, 150(1), 53-58.
35. Brown, V. (2003). PROTOTYPES, a model for mental health services for women of color living with HIV/AIDS. 131st Annual Meeting of the American Public Health Association, abstract 65759.
36. Burnam, M. A., Bing, E. G., Morton, S. C., Sherbourne, C., Fleishman, J. A., London, A. S., Vitiello, B., Stein, M., Bozzette, S. A., & Shaprio, M. F. (2001). Use of mental health and substance abuse treatment services among adults with HIV in the United States. Archives of General Psychiatry, 58, 729-736.
37. Camp, C. J. (2004). HIV/AIDS and aging: a cognitive clinical intervention. Grant number 1R21MH069199, NIH CRISP.
38. Carey, M. P., Weinhardt, L. S., & Carey, K. B. (1995). Prevalence of infection with HIV among the seriously mentally ill: review of research and implications for practice. Professional Psychology: Research and Practice, 26, 262-268.
39. Carmona, A., Knobel, H., & Guelar, A. (2000). Factors influencing survival in HIV infected patients treated with HAART. XIII International AIDS Conference, abstract TuOrB417, Durban, South Africa.
40. Catz, S. L. (2004). Adherence intervention-late middle-aged/older adults. Grant number 5R21MH065858, NIH CRISP.
41. Catz, S. L., Kelly, J. A., & Bogart, L. M. (2000). Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychology, 19, 124-133.
42. Celentano, D. D., Vlahov, D., Cohn, S., Shadle, V. M., Obasanjo, O., & Moore, R. D. (1998). Self-reported antiretroviral therapy in injection drug users. Journal of the American Medical Association, 280(6), 544-546.
43. Chesney, M. (2003). Adherence to HAART regimens. AIDS Patient Care and STDs, 17(4), 169-177.
44. Chesney, M. A., Morin, M., & Sherr, L. (2000a). Adherence to HIV combination therapy. Social Science Medicine, 50(11), 1599-1605.
45. Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., & Wu, A. W. (2000b). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. AIDS Care, 12(3), 255-266.
46. Clarke, S., Delamere, S., McCullough, L., Hopkins, S., Bergin, C., & Mulcahy, F. (2003). Assessing limiting factors to the acceptance of antiretroviral therapy in a large cohort of injecting drug users. HIV Medicine, 4(1), 33-37.
47. Cohen, R. A., Boland, R., & Paul, R. (2001). Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women. AIDS, 15, 341-345.
48. Cohn, S. E., Kammann, E., Williams, P., Currier, J. S., & Chesney, M. A. (2002). Association of adherence to mycobacterium avium complex prophylaxis and antiretroviral therapy with clinical outcomes in acquired immunodeficiency syndrome. Clinical Infectious Disease, 34(8), 1129-1136.
49. Colson, P. W., Franks, J., Davis, C., El-Sadr, W. M., & Mannheimer, S. B. (2003). Peer support for ART adherence among HIV-infected persons with severe mental disorders. 131st Annual Meeting of the American Public Health Association, abstract 67458.
50. Condra, J. H., Schleif, W. A., Blahy, O. M., Gabryelski, L. J., Graham, D. J., Quintero, J. C., Rhodes, A., Robbins, H. L., Roth, E., & Shivaprakash, M. (1995). In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors. Nature, 374(6522), 569-571.
51. Cook, R. L., Sereika, S. M., Hunt, S. C., Woodward, W. C., Erlen, J. A., & Conigliaro, J. (2001). Problem drinking and medication adherence among persons with HIV infection. Journal of General Internal Medicine, 16, 83-88.
52. Cook, J. A., Cohen, M. H., Grey, D., Kirstein, L., Burke, J., Anastos, K., Palacio, H., Richardson, J., Wilson, T. E., & Young, M. (2002). Use of highly active antiretroviral therapy in a cohort of HIV-seropositive women. American Journal of Public Health, 92, 82-87.
53. Cruess, D. G., Evans, D. L., Repetto, M. J., Gettes, D., Douglas, S. D., & Petitto, J. M. (2003). Prevalence, diagnosis, and pharmacologic treatment of mood disorders in HIV disease. Biological Psychiatry, 54(3), 307-316.
54. Cuffel, B. J., Alford, J., Fischer, E., & Owen, R. R. (1996). Awareness of illness in schizophrenia and outpatient treatment adherence. Journal of Nervous and Mental Disease, 184(11), 653-659.
55. Delahanty, D. L., Bogart, L. M., & Figler, J. L. (2004). Posttraumatic stress disorder symptoms, salivary cortisol, medication adherence, and CD4 levels in HIV-positive individuals. AIDS Care, 16(2), 247-260.
56. Deutsch, R., Ellis, R. J., & McCutchan, J. A. (2001). AIDS-associated mild neurocognitive impairment is delayed in the era of highly active antiretroviral therapy. AIDS, 15, 1898-1899.
57. Donovan, J. L. (1995). Patient decision making. The missing ingredient in compliance research. International Journal of Technology Assessment in Health Care, 11, 443-445.
58. Eldred, L. J., Wu, A. W., Chaisson, R. E., & Moore, R. D. (1998). Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18, 117-125.
59. Felkey, B. G. (1995). Adherence screening and monitoring. American Pharmacy, NS35(7), 52-53.
60. Ferrando, S. J., Wall, T. L., Batki, S. L., & Sorensen, J. L. (1996). Psychiatric morbidity, illicit drug use and adherence to zidovudine (AZT) among injection drug users with HIV disease. American Journal of Drug and Alcohol Abuse, 22(4), 475-487.
61. French, P. T., Chorost, S., Tesoriero, J., & Losowski, J. (2002). Treatment adherence among clients of adult day care programs in New York State: findings from a multi-site adherence study. 130th Annual Meeting of the American Public Health Association, abstract 38722.
62. Gebo, K. A., Keruly, J., & Moore, R. D. (2003). Association of social stress, illicit drug use, and health beliefs with nonadherence to antiretroviral therapy. Journal of General Internal Medicine, 18, 104-111.
63. Gerbino, P. P., (1993). Patient compliance. Annals of Pharmacotherapy, 27(9), S5-S19.
64. Gifford, A. L., & Groessl, E. J. (2002). Chronic disease self-management and adherence to HIV medications. Journal of Acquired Immune Deficiency Syndromes, 31, S163-S166.
65. Gifford, A. L., Bormann, J. E., Shively, M. J., Wright, B. C., Richman, D. D., & Bozzette, S. A. (2000). Predictors of self-reported adherence and plasma HIV concentration in patients on multidrug antiretroviral regimens. Journal of Acquired Immune Deficiency Syndromes, 23, 386-395.
66. Golin, C. E., Liu, H., Hays, R. D., Miller, L. G., Beck, C. K., Ickovics, J., Kaplan, A. H., & Wenger, N. S. (2002). A prospective study of predictors of adherence to combination antiretroviral medication. Journal of General Internal Medicine, 17, 756-765.
67. Gordillo, V., Del Amo, J., & Soriano, V. (1999). Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS, 13, 1763-1769.
68. Gourevitch, M. N. (2001). Interactions between HIV-related medications and methadone: an overview. Mount Sinai Journal of Medicine, 68, 227-228.
69. Graney, M. J., Bunting, S. M., & Russell, C. K. (2003). HIV/AIDS medication adherence factors: inner-city clinic patients' self-reports. Tennessee Medicine, 96, 73-78.
70. Gross, R., Bilker, W. B., Friedman, H. M., & Strom, B. L. (2001). Effects of adherence to newly initiated antiretroviral therapy on plasma viral load. AIDS, 15, 2109-2117.
71. Haikalis, S. (2000). HIV treatment adherence support with triply diagnosed HIV+ clients. XIII International AIDS Conference, abstract TuOrD389, Durban, South Africa.
72. Halkitis, P. N., Kutnick, A. H., Borkowski, T., & Parsons, J. T. (2002). Adherence to HIV medications and club drug use among gay and bisexual men. XIV International AIDS Conference, abstract ThPeE7856, Barcelona, Spain.
73. Halkitis, P. N., Kutnick, A. H., Rosof, E., Slater, S., & Parsons, J. T. (2003). Adherence to HIV medications in a cohort of men who have sex with men: impact of September 11th. Journal of Urban Health, 80(1), 161-166.
74. Haubrich, R. H., Little, S. J., Currier, J. S., Forthal, D. N., Kemper, C. A., Beall, G. N., Johnson, D., Dube, M. P., Hwang, J. Y., & McCutchan, J. A. (1999). The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. AIDS, 13, 1099-1107.
75. Herz, M. I., & Melville, C. (1980). Relapse in schizophrenia. American Journal of Psychiatry, 137, 801-805.
76. Hinkin, C. H. (2004). Predictor: medication adherence in HIV+ cocaine abusers. Grant number 5ROIDA013799, NIH CRISP.
77. Hinkin, C. H., Castellon, S. A., Durvasula, R. S., Hardy, D. J., Lam, M. N., Mason, K. I., Thrasher, D., Goetz, M. B., & Stefaniak, M. (2002). Medication adherence among HIV+ adults. Neurology, 59, 1944-1950.
78. Hogg, R., Heath, K. V., & Yip, B. (1998). Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. Journal of the American Medical Association, 279, 450-454.
79. Hogg, R., Yip, B., Chan, K., O'Shaughnessy, M., & Montaner, J. (2000). Non-adherence to triple combination therapy is predictive of AIDS progression and death in HIV-positive men and women. XIII International AIDS Conference, abstract TuOrB419, Durban, South Africa.
80. Holzemer, W. L., Corless, I. B., & Nokes, K. M. (1999). Predictors of self-reported adherence in persons living with HIV disease. AIDS Patient Care and STD, 13, 185-197.
81. Howard, A. A., Arnsten, J. H., Lo, Y., Vlahov, D., Rich, J. D., Schuman, P., Stone, V. E., Smith, D. K., & Schoenbaum, E. E. (2002). A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS, 16, 2175-2182.
82. Ickovics, J. R., & Meade, C. S. (2002a). Adherence to HAART among patients with HIV: breakthroughs and barriers. AIDS Care, 14(3), 309-318.
83. Ickovics, J. R., & Meade, C. S. (2002b). Adherence to antiretroviral therapy among patients with HIV: a critical link between behavioral and biomedical sciences. Journal of Acquired Immune Deficiency Syndromes, 31, 98-102.
84. Ickovics, J. R., & Meisler, A. W. (1997). Adherence in AIDS clinical trials: a framework for clinical research and clinical care. Journal of Clinical Epidemiology, 50(4), 385-391.
85. Ickovics, J. R., Hamburger, M. E., Vlahov, D., Schoenbaum, E. E., Schuman, P., Boland, R. J., & Moore, J. for the HIV Epidemiology Research Study Group (2001). Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. Journal of the American Medical Association, 285(11), 1466-1474.
86. Ingersoll, K. (2004). The impact of psychiatric symptoms, drug use, and medication regimen on non-adherence to HIV treatment. AIDS Care, 16(2), 199-211.
87. International AIDS Society, Yeni, P. G., Hammer, S. M., Carpenter, C. C. J., Cooper, D. A., Fischl, M. A., Gatell, J. M., Gazzard, B. G., Hirsch, M. S., Jacobsen, D. M., Katzenstein, D. A., Montaner, J. S. G., Richman, D. D., Saag, M. S., Schechter, M., Schooley, R. T., Thompson, M. A., Vella, S., & Volberding, P. A. (2002). Antiretroviral treatment for adult HIV infection in 2002. Journal of the American Medical Association, 288(2), 222-235.
88. Inungu, J., Beach, E. B., & Skeel, R. (2003). Challenges facing health professionals caring for HIV-infected drug users. AIDS Patient Care and STDs, 17, 333-344.
89. Isaac, L. M., & Tamblyn, R. M. (1993). Compliance and cognitive functioning: a methodological approach to measuring unintentional errors in medication compliance in the elderly. Gerontologist, 33, 772-781.
90. Jacobsen, H., Hanggi, M., & Ott, M. (1996). In vivo resistance to an HIV-1 protease inhibitor: mutations, kinetics and frequencies. Journal of Infectious Disease, 173, 1379-1387.
91. Jeanty, Y. J., Metsch, L. R., Wilkinson, J. D., & McCoy, C. B. (2003). An investigation of the correlates and predictors of adherence to HIV medication therapy in substance abusing populations. 131st Annual Meeting of the American Public Health Association, abstract 71243.
92. Kalichman, S. C., Ramachandran, B., & Catz, S. (1999). Adherence to combination antiretroviral therapies in HIV patients of low health literacy. Journal of General Internal Medicine, 14, 267-273.
93. Kleeberger, C. A., Phair, J. P., & Strathdee, S. A. (2001). Determinants of heterogeneous adherence to HIV antiretroviral therapies in the Multicenter AIDS Cohort Study. Journal of Acquired Immune Deficiency Syndrome, 26, 82-92.
94. Knobel, H., Carmona, A., & Guelar, A. (2000). Adherence in patients treated with HAART: influence in hospital admissions. XIII International AIDS Conference, abstract MoPeD2556, Durban, South Africa.
95. Krakow, D. S., Galanter, M., & Dermatis, H. (1998). HIV risk factors in dually diagnosed patients. American Journal of Addictions, 7, 74-80.
96. Kunches, L. M., Hirschhorn, L. R., Reinhalter, N., Decristofara, J., Musolino, J., & Flatley, J. (2002). Clinical outcomes and care patterns in HIV patients with co-occurring mental health diagnoses. 130th Annual Meeting of the American Public Health Association, abstract 39405.
97. Lesserman, J., Jackson, E. D., & Petitto, J. M. (1999). Progression to AIDS: the effects of stress, depressive symptoms and social support. Psychosomatic Medicine, 61, 397-406.
98. Lipsitz, J. D., Williams, J. B. W., Rabkin, J. G., Remien, R. H., Bradbury, M., El-Sadr, W., Goetz, R., Sorrell, S., & German, J. M. (1994). Psychopathology in male and female intravenous drug users with and without HIV infection. American Journal of Psychiatry, 151, 1662-1668.
99. Liu, H., Golin, C. E., Miller, L. G., Hays, R. D., Beck, K., Sanadaji, S., Christian, J., Maldonado, T., Duran, D., Kaplan, A. W., & Wenger, N. S. (2001). A comparison study of multiple measures of adherence to HIV protease inhibitors. Annals of Internal Medicine, 134, 968-977.
100. Lucas, G., Chaisson, R., & Moore, R. (1999). Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions. Annals of Internal Medicine, 131, 81-87.
101. Lucas, G. M., Cheever, L. W., Chaisson, R. E., & Moore, R. D. (2001). Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection. Journal of Acquired Immune Deficiency Syndrome, 27, 251-259.
102. Lucas, G. M., Gebo, K. A., Chaisson, R. E., & Moore, R. D. (2002). Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS, 16, 767-774.
103. Lyketsos, C. G., Hoover, D. R., Guccione, M., Senterfitt, W., Dew, M. A., Wesch, J., Van Raden, M. J., Treisman, G. J., & Morgenstern, H. for the Multicenter AIDS Cohort Study (1993). Depressive symptoms as predictors of medical outcomes in HIV infection. Journal of the American Medical Association, 270(21), 2563-2567.
104. Maj, M. (1996). Depressive syndromes and symptoms in subjects with human immunodeficiency virus infection. British Journal of Psychiatry, 168 (Supplement 30), 117-122.
105. Mannheimer, S., Friedland, G., Matts, J., Child, C., & Chesney, M. A. (2002). The consistency of adherence to antiretroviral therapy predicts biologic outcomes for HIV persons in clinical trials. Clinical Infectious Diseases, 34, 1115-1121.
106. Martin, E. M. (2004). Cognitive neuropsychology of HIV and MDMA abuse. Grant number 5RO1DA013800, NIH CRISP.
107. Mayne, T. J., Vittinghoff, E., Chesney, M. A., Barrett, D. C., & Coates, T. J. (1996). Depressive effect and survival among gay and bisexual men infected with HIV. Archives of Internal Medicine, 156, 2233-2238.
108. McCance-Katz, E. F., Gourevitch, M. N., Arnsten, J., Sarlo, J., Rainey, P., & Jatlow, P. (2002). Modified directly observed therapy (MDOT) for injection drug users with HIV disease. American Journal on Addiction, 11(4), 217-278.
109. McDonald, H. P., Garg, A. X., & Haynes, R. B. (2002). Interventions to enhance patient adherence to medication prescriptions. Journal of the American Medical Association, 288(22), 2868-2879.
110. McEvoy, J. P., Aland, J., & Wilson, W. J. (1981). Measuring chronic schizophrenic patients' attitudes toward their illness and treatment. Hospital and Community Psychiatry, 32, 856-858.
111. McPherson-Baker, S., Malow, R. M., Penedo, F., Jones, D. L., Schneiderman, N., & Klimas, N. G. (2000). Enhancing adherence to combination antiretroviral therapy in non-adherent HIV-positive men. AIDS Care, 12(4), 399-404.
112. Meichenbaum, D., & Turk, C. (1987). Facilitating treatment adherence: a practitioner's guidebook. New York: Plenum Press.
113. Mellins, C. A., Havens, J. F., McCaskill, E., Leu, C. S., Brudney, K., & Chesney, M. (2002). Mental health, substance use and disclosure are significantly associated with the medical treatment adherence of HIV-infected mothers. Psychology, Health and Medicine, 7, 451-460.
114. Mellins, C. A., Kang, E., Leu, C., Havens, J., & Chesney, M. (2003). Longitudinal study of mental health and psychosocial predictors of medical treatment adherence in mothers living with HIV disease. AIDS Patient Care and STDs, 17, 407-416.
115. Moatti, J. P., Carrieri, M. P., & Spire, B. (2000). Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment. AIDS, 14, 51-155.
116. Montaner, J. S. G., Reiss, P., & Cooper, D. (1998). A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients. Journal of the American Medical Association, 279, 930-937.
117. Morris, L. S., & Schulz, R. M. (1992). Patient compliance: an overview. Journal of Clinical Pharmacy and Therapeutics, 17, 183-195.
118. Morrison, M. F., Petito, J. M., Have, T. T., Gettes, D. R., Chiapini, M. S., Weber, A. L., Brinker-Spence, P., Bauer, R. M., & Douglas, S. D. (2002). Depressive and anxiety disorders in women with HIV Infection. American Journal of Psychiatry, 159, 789-796.
119. Mostashari, F., Riley, E., Selwyn, P. A., & Altice, F. L. (1998). Acceptance and adherence with antiretroviral therapy among HIV-infected women in a correctional facility. Journal of Acquired Immune Deficiency Syndromes, 18, 341-348.
120. Muma, R. D., Ross, M. W., Parcel, G. S., & Pollard, R. B. (1995). Zidovudine adherence among individuals with HIV infection. AIDS Care, 7(4), 439-447.
121. Murphy, D. A., Roberts, K. J., Martin, D. J., Marelich, W., & Hoffman, D. (2000). Barriers to antiretroviral adherence among HIV-infected adults. AIDS Patient Care and STDs, 14, 47-58.
122. Murphy, D. A., Sarr, M., Durako, S. J., Moscicki, A. B., Wilson, C. M., & Muenz, L. R. (2003). Barriers to HAART adherence among human immunodeficiency virus-infected adolescents. Archives of Pediatric Adolescent Medicine, 157(3), 249-255.
123. Murri, R., Antinori, A., Ammassari, A., Nappa, S., Orofino, G., Abrescia, N., Mussini, C., Monforte, A. D., & Wu, A. W. for the AdICoNA Study Group (2002). Physician estimates of adherence and the patient-physician relationship as a setting to improve adherence to antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes, 31, S158-S162.
124. Nieuwkerk, P. T., Sprangers, M. A. G., Burger, D. M., Hoetelmans, R. M. W., Hugen, P. W. H., Danner, S. A., Ende, M. E., van der Schneider, M. M. E., Schrey, G., Meenhorst, P. L., Sprenger, H. G., Kauffmann, R. H., Jambroes, M., Chesney, M. A., Wolf, F., & de Lange, J. M. A. for the Athena Project (2001). Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study. Archives of Internal Medicine, 161, 1962-1968.
125. Olalla, P. G., de Knobel, H., Carmona, A., Guelar, A., Lopez-Colomes, J. L., & Cayla, J. A. (2002). Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes, 30, 105-110.
126. Owen, R. R., Fischer, E. P., Booth, B. M., & Cuffel, B. J. (1996). Medication noncompliance and substance abuse among patients with schizophrenia. Psychiatric Services, 47(8), 853-858.
127. Palella, F. J., Delaney, K. M., & Moorman, A. C. (1998). Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. New England Journal of Medicine, 338, 853-860.
128. Palepu, A., Horton, N. J., Tibbetts, N., Meli, S., & Samet, J. H. (2004). Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment. Addiction, 99(3), 361-368.
129. Palmer, N. B., Salcedo, J., Miller, A. L., Winiarski, M., & Arno, P. (2003). Psychiatric and social barriers to HIV medication adherence in a triply diagnosed methadone population. AIDS Patient Care and STDs , 17, 635-644.
130. Parsons, J. T. (2004). Adherence intervention for HIV+ alcohol users. Grant number 5RO1AA13556, NIH CRISP.
131. Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., Wagener, M. M., & Singh, N. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21-30.
132. Paterson, D. L., Potoski, B., & Capitano, B. (2002). Measurement of adherence to antiretroviral medications. Journal of Acquired Immune Deficiency Syndromes, 31, S103-S106.
133. Patterson, T. L., Shaw, W. S., & Semple, S. J. (1996). Relationship of psychosocial factors to HIV disease progression. Annals of Behavioral Medicine, 18, 30-39.
134. Perno, C. F., Ceccherini-Silberstein, F., Luca, A., de Cozzi-Lepri, A., Gori, C., Cingolani, A., Bellocchi, M. C., Trotta, M. P., Piano, P., Forbici, F., Scasso, A., Vullo, V., Monforte, A. D., & Antinori, A. for the AdICoNA Study Group (2002). Virologic correlates of adherence to antiretroviral medications and therapeutic failure. Journal of Acquired Immune Deficiency Syndromes, 31, S118-S122.
135. Perretta, P., Akiskal, H. S., Nisita, C., Lorenzetti, C., Zaccagnini, E., Della Sant, M., & Cassano, G. B. (1998). The high prevalence of bipolar II and associated cyclothymic and hyperthymic temperaments in HIV patients. Journal of Affective Disorders, 50(2-3), 215-224.
136. Perry, S., Bangsberg, D. B., Charlebois, E. D., Clark, R., Karasic, D., Dilley, J., Sorensen, J., & Moss, A. R. (2002). Depressive symptoms predict adherence, treatment duration and survival in an urban poor cohort. XIV International AIDS Conference, abstract TuPeC4724, Barcelona, Spain.
137. Power, R., Koopman, C., Volk, J., Israelski, D. M., Stone, L., Chesney, M. A., & Spiegel, D. (2003). Social support, substance use, and denial in relationship to antiretroviral adherence among HIV-infected persons. AIDS Patient Care and STDs, 17(5), 245-252.
138. Prentiss, D. E., Balmas, M. G., Power, R., & Israelski, D. M. (2002). Use of marijuana among people with HIV and its relationship to adherence to antiretroviral treatment, use of alternative therapies and complete viral suppression in a public health care setting in northern California. XIV International AIDS Conference, abstract WePeB6008, Barcelona, Spain.
139. Press, N., Tyndall, M. W., Wood, E., Hogg, R. S., & Montaner, J. S. G. (2002). Virologic and immunologic response, clinical progression, and highly active antiretroviral therapy adherence. Journal of Acquired Immune Deficiency Syndromes, 31, S112-S117.
140. RachBeisel, J., Scott, J., & Dixon, L. (1999). Co-occurring severe mental illness and substance use disorders: a review of recent research. Psychiatric Services, 50(11), 1427-1434.
141. Rigsby, M., Rosen, M., Beauvais, J., Cramer, J., Rainey, P., O'Malley, S., Dieckhaus, K., & Rounsaville, B. (2000). Cue-dose training with monetary reinforcement: pilot study of an antiretroviral adherence intervention. Journal of General Internal Medicine, 15, 841-847.
142. Roberts, K., & Mann, T. (2000). Barriers to antiretroviral medication adherence in HIV-infected women. AIDS Care, 12, 377-386.
143. Roberts, N. A. (1995). Drug resistance patterns of saquinavir and other protease inhibitors. AIDS, 9(Supplement), S27-S32.
144. Royall, D. R., Cordes, J., & Polk, M. (1997). Executive control and the comprehension of medical information by elderly retirees. Experiments in Aging Research, 23, 301-313.
145. Sacktor, N., McDermott, M. P., & Marder, K. (2002). HIV-associated cognitive impairment before and after the advent of combination therapy. Journal of Neurovirology, 8, 136-142.
146. Safren, S. A., Gershuny, B. S., & Hendriksen, E. (2003). Symptoms of posttraumatic stress and death anxiety in persons with HIV and medication adherence difficulties. AIDS Patient Care and STDs, 17, 657-664.
147. Sambamoorthi, U., Walkup, J., Olfson, M., & Crystal, S. (2000). Antidepressant treatment and health services utilization among HIV-infected Medicaid patients diagnosed with depression. Journal of General Internal Medicine, 15, 311-320.
148. Samet, J. H. (2004). Medication adherence in alcohol abusing HIV patients. Grant number 5RO1AA011785, NIH CRISP.
149. Samet, J. H., Horton, N. J., Dukes, K., Meli, S., Labelle, C., & Freedberg, K. A. (2002). A randomized controlled trial of a multidimensional intervention to enhance adherence to antiretroviral therapy in HIV-infected patients with a history of alcohol problems. XIV International AIDS Conference, abstract MoPeB3286, Barcelona, Spain.
150. Savini, C. J., James, C. W., & Diguglielmo, D. J. (2003). Survey of patient and clinician attitudes on adherence in a rural HIV clinic. Journal of the Association of Nurses in AIDS Care, 14, 72-75.
151. Schuman, P., Ohmit, S. E., Moore, J., Schoenbaum, E., Boland, R., Rompalo, A., Soloman, L., & the HERS group (2001). Perceived need for and use of mental health services by women living with or at risk of human immunodeficiency virus infection. Journal of the American Medical Women's Association, 56, 4-8.
152. Seines, O. (2002). Neurocognitive aspects of medication adherence in HIV infection. Journal of Acquired Immune Deficiency Syndromes, 31, S132-S135.
153. Serban, G., & Thomas, A. (1974). Attitudes and behaviors of acute and chronic schizophrenic patients regarding ambulatory treatment. American Journal of Psychiatry, 131, 991-995.
154. Servellen, G., van Chang, B., Garcia, L., & Lombardi, E. (2002). Individual and system level factors associated with treatment nonadherence in human immunodeficiency virus-infected men and women. AIDS Patient Care, 16(6), 269-281.
155. Simoni, J. M., Frick, P. A., Lockhart, D., & Liebovitz, D. (2002).
156. Simoni, J. M., Frick, P. A., Pantalone, D. W., & Turner, B. J. (2003). Antiretroviral adherence interventions: a review of the current literature and ongoing studies. Topics in HIV Medicine, 11(6), 185-198.
157. Singh, N., Squier, C., Sivek, C., Wagener, M., Nguyen, M. H., & Yu, V. L. (1996). Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance. AIDS Care, 8(3), 261-269.
158. Smith, M. Y., Rapkin, B. D., Morrison, A., & Kammerman, S. (1997). Zidovudine adherence in persons with AIDS: the relation of patient beliefs about medication to self-termination of therapy. Journal of General Internal Medicine, 12, 216-223.
159. Sorensen, J. L., Mascovich, A., Wall, T. L., Dephillipis, D., Batki, S. L., & Chesney, M. (1998). Medication adherence strategies for drug abusers with HIV/AIDS. AIDS Care, 10(3), 297-312.
160. Starace, F., Ammassari, A., Trotta, M. P., Murri, R., Longis, P., de Izzo, C., Scalzini, A., Monforte, A. D., Wu, A. W., & Antinori, A. the NeuroICoNA Study Groups (2002). Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes, 31, S136-S139.
161. Stein, M. D., Rich, J. D., Maksad, J., Chen, M. H., Hu, P., Sobota, M., & Clarke, J. (2000). Adherence to antiretroviral therapy among HIV-infected methadone patients: effect of ongoing illicit drug use. American Journal of Drug and Alcohol Abuse, 26, 195-205.
162. Stone, V. E., Hogan, J. W., & Schuman, P. (2001). Antiretroviral regimen complexity, self-reported adherence, and HIV patients' understanding of their regimens: survey of women in the HER study. Journal of the Acquired Immune Deficiency Syndrome, 28, 124-131.
163. Strathdee, S. A., Palepu, A., Cornelisse, P. G. A., Yip, B., O'Shaughnessy, M. V., Montaner, J. S. G., Schechter, M. T., & Hogg, R. S. (1998). Barriers to use of free antiretroviral therapy in injection drug users. Journal of American Medical Association, 280(6), 547-549.
164. Thomas, N., Laine, C., Hauck, W., Cosler, L., & Turner, B. J. (2001). Psychiatric care and drug users' pharmacy-based adherence to combination antiretroviral therapy. 129th Annual Meeting of the American Public Health Association, abstract 26678.
165. Tobin, J. N. (2004). Behavioral interventions for women with HIV/AIDS. Grant number 5RO1MH061208, NIH CRISP.
166. Tozzi, V., Balestra, P., & Galgani, S. (2001). Changes in neurocognitive performance in a cohort of patients treated with HAART for 3 years. Journal of Acquired Immunodeficiency Syndrome, 28, 19-27.
167. Trotta, M. P., Ammassari, A., Melzi, S., Zaccarelli, M., Ladisa, N., Sighinolfi, L., Mura, M. S., Monforte, A. D., & Antinori, A. for the AdICoNA Study Group (2002). Treatment-related factors and highly active antiretroviral therapy adherence. Journal of Acquired Immune Deficiency Syndromes, 31, S128-S131.
168. Tucker, J. S., Burnam, M. A., Sherbourne, C. D., Kung, F. Y., & Gifford, A. L. (2003). Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. American Journal of Medicine, 114, 573-580.
169. Tuldra, A., & Wu, A. W. (2002). Interventions to improve adherence to antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes, 31, S154-S157.
170. Turner, B. (2001). Improving on a coin toss to predict patient adherence to medications. Annals of Internal Medicine, 134(10), 1004-1006.
171. Turner, B. J., Newschaffer, C. J., Zhang, D., Cosler, L., & Hauck, W. W. (2000). Antiretroviral use and pharmacy-based measurement of adherence in postpartum HIV-infected women. Medical Care, 38, 911-925.
172. Turner, B., Fleishman, J. A., Wenger, N., London, A. S., Burnam, M. A., Shapiro, M. F., Bing, E. G., Stein, M. D., Longshore, D., & Bozzette, S. A. (2001). Effects of drugs abuse and mental disorders on use and type of antiretroviral therapy in HIV-infected persons. Journal of General Internal Medicine, 16, 625-633.
173. Turner, B. J., Laine, C., Cosler, L., & Hauck, W. W. (2003). Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users. Journal of General Internal Medicine, 18, 248-257.
174. Van Putten, T., Crumpton, E., & Yale, C. (1976). Drug refusal in schizophrenia and the wish to be crazy. Archives of General Psychiatry, 33, 1443-1446.
175. Van Putten, T., May, P. R. A., & Marder, S. R. (1984). Response to antipsychotic medication: the doctor's and the consumer's view. American Journal of Psychiatry, 141, 16-19.
176. Vermeire, E., Hearnshaw, H., Royen, P., & van & Denekens, J. (2001). Patient adherence to treatment: three decades of research. A comprehensive review. Journal of Clinical Pharmacy and Therapeutics, 26, 331-342.
177. Wagner, G. J., Remien, R. H., Carballo-Dieguez, A., & Dolezal, C. (2002). Correlates of adherence to combination antiretroviral therapy among members of HIV-positive mixed status couples. AIDS Care, 14, 105-109.
178. Wagner, G. J., Kanouse, D. E., Koegel, P., & Sullivan, G. (2003). Adherence to antiretrovirals among persons with serious mental illness. AIDS Patient Care and STDs, 17(4), 179-186.
179. Wagner, J. H., Justice, A. C., Chesney, M., Sinclair, G., Weissman, S., & Rodriguez-Barradas, M. (2001). Patient- and provider-reported adherence: toward a clinically useful approach to measuring antiretroviral adherence. Journal of Clinical Epidemiology Supplement, 54 (Supplement), S91-S98.
180. Weber, R., Christen, L., Christen, S., Tschopp, S., Znoj, H., Schneider, C., Schmitt, J., Opravil, M., Gunthard, H. F., Ledergerber, B., & Swiss HIV Cohort Study (2004). Effect of individual cognitive behaviour intervention on adherence to antiretroviral therapy: prospective randomized trial. Antiviral Therapy, 9(1), 85-89.
181. Weiden, P. J., Dixon, L., & Frances, A. (1991). Neuroleptic noncompliance in schizophrenia. Schizophrenia Research, 1, 285-296.
182. Weidle, P. J., Ganera, C. E., Irwin, K. L., McGowan, J. P., Ernst, J. A., Olivo, N., & Holmberg, S. D. (1999). Adherence to antiretroviral medications in an inner-city population. Journal of Acquired Immune Deficiency Syndromes, 22, 498-502.
183. Weiner, M. W. (2004). Chronic alcohol abuse-effects on HIV CNS morbidity. Grant number 5P01AA011493, NIH CRISP.
184. Weiss, S. M. (2004). Behavioral interventions for women with HIV/AIDS. Grant number 5RO1MH055463, NIH CRISP.
185. Wilson, J. D., & Enoch, M. D. (1967). Estimation of drug rejection by schizophrenic in-patients, with analysis of clinical factors. British Journal of Pscyhiatry, 113, 209-211.
186. Wilson, T. E., Barron, Y., & Cohen, M. (2002). Adherence to antiretroviral therapy and its association with sexual behavior in a national sample of women with human immunodeficiency virus. Clinical Infectious Disease, 34, 529-534.
187. Wohl, D. A., Stephenson, B. L., Golin, C. E., Kiziah, C. N., Rosen, D., Ngo, B., Liu, H., & Kaplan, A. H. (2003). Adherence to directly observed antiretroviral therapy among human immunodeficiency virus-infected prison inmates. Clinical Infections Diseases, 36(12), 1572-1576.
188. Wohler-Torres, B., Valverde, E., Anderson-Mahoney, P., Barragan, M., Loughlin, A. M., & Metsch, L. R. (2002). System barriers to HIV medical care appointment compliance: results of the ARTAS study. 130th Annual Meeting of the American Public Health Association, abstract 45925.
189. Wu, A. W., Ammassari, A., & Antinori, A. (2002). Adherence to antiretroviral therapy: where are we, and where do we go from here? Journal of Acquired Immune Deficiency Syndromes, 31, S95-S97.
190. Young, J. L., Zonana, H. V., & Shepler, L. (1986). Medication noncompliance in schizophrenia: codification and update. Bulletin of the American Academy of Psychiatry and the Law, 14, 105-122.
191. Zinkernagel, C., Taffe, P., Rickenbach, M., Amiet, R., Ledergerber, B., Volkart, A. C., Rauchfleisch, U., Kiss, Á., Werder, V., Vernazza, P., & Battegay, M. (2001). Importance of mental health assessment in HIV-infected outpatients. Journal of Acquired Immune Deficiency Syndromes, 28, 240-249.